Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹1.7 CrAccepted-AOC | ₹1.7 Cr | L1 | Accepted-AOC For Sr. Nos. 8 to 13 |
| 2 | L1₹8.3 CrAccepted-AOC 1ST AND 2ND FLOOR NXT TOWER 2 EMBASSY MANYATA BUSINESS PARK NAGAVARA VILLAGE KASABA HOBLI BANGALORE KARNATAKA INDIA 560045 | BANGALORE | BANGALORE | KARNATAKA | 560045 | ₹8.3 Cr | L1 | Accepted-AOC For Sr. Nos. 1 to 7 |
| 3 | L3₹1.9 CrRejected-AOC | ₹1.9 Cr | L3 | Rejected-AOC L3 |
Tender Value
Refer Docs
EMD Value
₹15 L
Closing Date
22 Sept 2022, 5:00 pmClosed
Director
Directorate of Health Service Panaji Goa
TENDER FOR DIABETES MANAGEMENT AND SUPPLY OF INSULINS
2022_DHS_4937_1
97/PT/DHS/MSD/2022-23/697
Open Tender
Drugs and Pharmaceutical Products
Item Rate
1825 days
Panaji-Goa
Please refer Tender documents.
6 documents required · 6 mandatory
₹2,000
₹15 L
Yes
Directorate of Health Service
17 Nov 2023
8 Aug 2022
27 Sept 2022
8 Aug 2022
22 Sept 2022
25 Aug 2022
22 Aug 2022
Soluble Insulin inj IP, Monocomponent Human Insulin biosynthetic (r-DNA origin) each ml solution contains 40 iu
Manufacturer 1
Manufacturer 2
Manufacturer 3
Manufacturer 4
Manufacturer 5
Manufacturer 6
Manufacturer 7
Biphasic Isophane Insulin inj IP (30% as soluble insulin & 70% as isophane insulin OR 25% as soluble insulin & 75% as isophane insulin), Monocomponent Human Insulin biosynthetic (r-DNA origin) each ml suspension contains 40 iu Packing: 10 ml vial
Manufacturer 1
Manufacturer 2
Manufacturer 3
Manufacturer 4
Manufacturer 5
Manufacturer 6
Manufacturer 7
Inj Insulin Human Isophane 40IU/ml (NPH)
Manufacturer 1
Manufacturer 2
Manufacturer 3
Manufacturer 4
Manufacturer 5
Manufacturer 6
Manufacturer 7
Premixed Human Insulin (30% as soluble &70% as isophane insulin OR 25% as soluble &75%as isophane insulin), 100 IU/ml in 3 ml cartridges
Manufacturer 1
Manufacturer 2
Manufacturer 3
Manufacturer 4
Manufacturer 5
Manufacturer 6
Manufacturer 7
Rapid acting Human Insulin 100 iu/ ml in 3ml Cartridges
Manufacturer 1
Manufacturer 2
Manufacturer 3
Manufacturer 4
Manufacturer 5
Manufacturer 6
Manufacturer 7
Isophane Human Insulin 100 IU/ml in 3 ml penfill
Manufacturer 1
Manufacturer 2
Manufacturer 3
Manufacturer 4
Manufacturer 5
Manufacturer 6
Manufacturer 7
Basal Insulin Analogue Inj (r-DNA origin) Glargine 100iu/ml in 3ml cartridges
Manufacturer 1
Manufacturer 2
Manufacturer 3
Manufacturer 4
Manufacturer 5
Manufacturer 6
Manufacturer 7
Premix Insulin Analogue (30% Rapid Acting Analogue and70%protaminated suspension) 100 IU/Ml in 3 ml cartridges
Manufacturer 1
Manufacturer 2
Manufacturer 3
Manufacturer 4
Manufacturer 5
Manufacturer 6
Manufacturer 7
Ultra Fast Acting Insulin Aspart 100 IU/ml 3 ml PFS
Manufacturer 1
Manufacturer 2
Manufacturer 3
Manufacturer 4
Manufacturer 5
Manufacturer 6
Manufacturer 7
Rapid Acting Analogue Insulin 100 IU/ml 3 ml cartridges
Manufacturer 1
Manufacturer 2
Manufacturer 3
Manufacturer 4
Manufacturer 5
Manufacturer 6
Manufacturer 7
Rapid Acting Analogue Insulin 100 IU/ml 3 ml PFS
Manufacturer 1
Manufacturer 2
Manufacturer 3
Manufacturer 4
Manufacturer 5
Manufacturer 6
Manufacturer 7
Ultra long acting Basal Insulin analogue inj (r-DNA origin)degludec 100IU/ml in 3ml PFS
Manufacturer 1
Manufacturer 2
Manufacturer 3
Manufacturer 4
Manufacturer 5
Manufacturer 6
Manufacturer 7
Insulin degludec/Insulin Aspart (r-DNA origin) (70% soluble Insulin Degludec and 30 % soluble Insulin Aspart) 100 IU/ml in 3.0 ml cartridges
Manufacturer 1
Manufacturer 2
Manufacturer 3
Manufacturer 4
Manufacturer 5
Manufacturer 6
Manufacturer 7
stage.html
html • 0.05 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
aoc.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .